LC-2

N/A

Report date: 2022/02/18 17:42:24

NME

Base Information

Drug NameLC-2

Drug Alias NameLC-2

ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)

Mechanisms of ActionKRAS G12C inhibitors

TargetsGTPase KRasKRAS G12C

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesYale University

China Registration ClassN/A

Active CompaniesYale University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A